SCOPE

This technical standard describes the U.S. Department of Energy Laboratory
Accreditation Program (DOELAP) for radiobioassay, in support of worker health and safety. DOELAP accreditation involves performance testing and documentation of program elements important to the long-term quality assurance of a radiobioassay program, and assessment of the program's ability to accurately perform, record, and report the measurement of radioactive material within the human body and in biological samples from it. DOELAP also provides a qualification process for interested commercial vendors of radiobioassay services. The qualification process is nearly identical to that for accreditation, thus the criteria in this technical standard are applicable to a vendor applying for qualification.
DOELAP, though, does not evaluate the design and implementation of a radiobioassay program at a DOE site nor evaluate any process used to determine internal dose. Accreditation involves:
a. Performance testing a radiobioassay program based on ANSI/HPS N13.30-2011, Performance Criteria for Radiobioassay.
b. Onsite assessment of a radiobioassay program's quality assurance, staffing, facilities, equipment, documentation, records, etc., by DOELAP assessors using information contained in this and other DOELAP technical standards and the DOELAP handbook.
References herein to an ANSI standard pertain to the above version. However, as this consensus standard is subject to change, the reference may be revised as appropriate. Notice will be given in the Federal Register when a new ANSI standard is to be implemented, along with an appropriate timeframe for implementation.
1.2. Direct or indirect radiobioassay methods used for identifying and quantifying radionuclides are included in the scope of DOELAP for radiobioassay. Accreditation under this standard applies to methods employed in a contractor dose monitoring program conducted in compliance with 10 C.F.R. 835.402(d).
1.3. This standard is specific to the technical characteristics of, and the quality assurance program supporting, a radiobioassay program at a DOE site and that of a qualified vendor's program. Biokinetic models and internal dosimetry protocols used to determine radioactive material intake and internal dose are not included in the scope of the accreditation program. Further, no consideration is given to any administrative aspect such as report format or compliance with requirements outside of 10 C.F.R. Part 830, Nuclear Safety Management, and 10 C.F.R. Part 835, Occupational Radiation Protection.
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GENERAL REQUIREMENTS AND INFORMATION
2.1. ANSI/HPS N13.30-2011 is incorporated into this standard. DOELAP may modify any specification as necessary to assure conservatism in the accreditation process. Any modification will be discussed in the DOELAP Handbook.
2.2.
A radiobioassay system shall be tested if it is used to demonstrate compliance with 10 C.F.R. 835.402(d).
2.3. The applicant shall select the testing category or categories for each radiobioassay system.
2.4. An applicant applying for accreditation in an entire performance testing category shall:
a. be capable of measuring each radionuclide in that category, and b. report results for each radionuclide requested by the PTL.
2.5. Specific information supporting accreditation shall be submitted to the PTL in the application. For example, the applicant would provide the following information:
a. The performance category or categories to be tested in.
b. A concise description of each radiobioassay system to be performance tested.
2.6
The applicant shall implement a quality assurance program (QAP). 10 CFR 830.122 prescribes basic components of and criteria for a QAP and HPS/ANSI N13.30-2011 establishes QAP criteria for a radiobioassay program. The applicant's QAP shall address the criteria applicable to its program. Appendix A provides a general summary of the criteria and a basis for onsite assessment guidance.
2.7. The Senior Technical Manager (STM), as defined in DOE-STD-1111-2013, coordinates performance testing and the onsite assessment with the authorized representative.
2.8. The applicant shall report the performance testing measurement results to the PTL by the requested date. Failure by an applicant to submit all measurement results by that date may result in failure of the affected test category; failure under this circumstance will not be remedied through a subsequent retest.
2.9. The PTL will report the evaluated performance testing results to the applicant after the evaluations have been compiled. An estimate of the uncertainty of the assigned values of activity will be included. The PTL will not accept any request to change or void any reported result after the test results have been distributed. Prior to distribution of the testing results, the STM may, at the STM's discretion, accept a DOELAP Administrator will provide formal notification to a renewal applicant that the indirect radiobioassay accreditation has expired.
ONSITE ASSESSMENT
To become accredited or designated a qualified vendor, an applicant shall demonstrate its ability to conduct a competent radiobioassay program as specified by this technical standard. The onsite assessment will assess the organization, quality assurance, documentation, and technical aspects of the radiobioassay program; for accreditation, the assessment will address the program's ability to support dose determinations from occupational radiation exposure. For initial accreditation or vendor qualification, an onsite assessment will occur after performance testing has been satisfactorily completed. Any identified concern or deficiency shall be addressed as explained in DOE-STD-1111-2013. General onsite assessment information may also be found in the handbook.
REFERENCES
The current versions of the following documents allow for complete implementation of this technical standard:
U.S. Code of Federal Regulations, Title 10, Part 820, Procedural Rules for DOE Nuclear Activities.
Applicant.
A DOE site radiobioassay program that has submitted an application for DOELAP accreditation and is participating in the accreditation process. An applicant may also be a commercial vendor that has applied to DOELAP to be a Qualified Vendor.
Assessment. An onsite review undertaken by DOELAP to assess the competence of a radiobioassay program, based on this standard, for a defined scope of accreditation.
NOTE: Assessing the competence of a program involves assessing the entire radiobioassay operations of a contractor or vendor, including the competence of the personnel, the validity of the measurement methodology, and the validity of the measurement results.
Authorized Representative. A person identified by the applicant who provides a single point of contact for coordinating with the PTL the applicant's participation in the performance testing and the onsite assessment processes.
Conditions of Accreditation.
A regulatory document, issued by DOELAP, that specifies the performance categories, radiobioassay systems, and quality assurance measures that are being accredited.
Direct Radiobioassay. The assessment of radionuclides and quantities in the human body by detection of the radiations emitted from the individual and typically measured by external detection systems (also known as in vivo radiobioassay).
Indirect Radiobioassay. The measurement or analysis of radionuclides in biological samples from a human body (also known as in vitro radiobioassay).
Performance Testing Laboratory.
A laboratory authorized by DOE to conduct performance testing specified by this standard. The DOE Radiological and Environmental Sciences Laboratory, located at Idaho Falls, Idaho, is the DOELAP performance testing laboratory.
Radiobioassay Program. The personnel, management, quality assurance, operation, and radiobioassay system(s) used to ascertain an amount of radioactive material resulting from an occupational exposure.
Radiobioassay System. The software, analytical method(s), measurement method(s), and detection method(s) used to identify and quantify radioactive material in the human body or biological samples.
